Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GNPS Native Metabolomics - Chymotrypsin Binding Validation Experiments

ABSTRACT: Native metabolomics method validation for chymotrypsin. 1. Limit of detection Mollasamide- Chymotrypsin 2. Flowinjection of Mollasamide over UHPLC gradients (with make-up). 3. Binding tests with chymotrypsin and different standards.

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Rivularia (ncbitaxon:373984)

SUBMITTER: Daniel Petras

PROVIDER: MSV000088586 | GNPS | Sat Dec 18 12:47:00 GMT 2021

REPOSITORIES: GNPS

ACCESS DATA

Json Xml

Similar Datasets

Native Metabolomics - Chymotrypsin Binding Validation Experiments

Project description:Native metabolomics method validation for chymotrypsin. 1. Limit of detection Mollasamide- Chymotrypsin 2. Flowinjection of Mollasamide over UHPLC gradients (with make-up). 3. Binding tests with chymotrypsin and different standards.

2021-12-18 | MSV000088586 | MassIVE

Validation data for Lawrence Livermore Microbial Detection Arrays

Project description:This SuperSeries is composed of the following subset Series: GSE24626: Validation data for Lawrence Livermore Microbial Detection Array version 2 GSE24699: Validation data for Lawrence Livermore Microbial Detection Array version 1 Refer to individual Series

2010-10-15 | E-GEOD-24700 | biostudies-arrayexpress

Discovery, Verification, and Validation of Walnut Protein Marker Peptides Using LC-MS/MS Approaches

Project description:A key requirement of liquid chromatography-mass spectrometry (LC-MS)-based allergenic food protein analysis methods is to use protein marker peptides with good analytical performances in LC-MS analysis of commercial processed foods. In this study, we developed a multistage walnut protein marker peptide selection strategy involving marker peptide discovery and verification and LC-MS validation of chemically equivalent stable isotope-labeled peptides. This strategy proposed three walnut protein marker peptides, including two new marker peptides. Our LC-MS-based walnut protein analysis method using the three stable isotope-labeled peptides showed acceptable linearity (R2 >0.99), matrix effects (coefficient of variation <±15%), sensitivity (limit of detection >0.3 pg/μL, limit of quantification >0.8 pg/μL), recovery (85.1–103.4%), accuracy, and precision (coefficient of variation <10%). In conclusion, our multistage marker peptide selection strategy effectively selects specific protein marker peptides for sensitive detection and absolute quantification of walnut proteins in LC-MS analysis of commercial processed foods.

2023-07-31 | PXD043010 | Pride

Native single molecule sequencing and de novo assembly of Hepatitis B Virus to detect 5mCpG

Project description:Methylation of Hepatitis B Virus (HBV) DNA in a CpG context (5mCpG) can alter the expression patterns of viral genes related to infection and cellular transformation. Moreover, it may also provide clues to why certain infections are cleared, or persist with or without progression to cancer. The detection of 5mCpG often requires techniques that damage DNA or introduce bias through a myriad of limitations. Therefore, we developed a method for the detection of 5mCpG on the HBV genome that does not rely on bisulfite conversion or PCR. Moreover, using the developed technique, we have provided the first de novo assembly of native HBV DNA, as well as the first landscape of 5mCpG from native HBV sequences

2021-01-05 | GSE162518 | GEO

Prediction, detection, and validation of isotope peaks in mass spectrometry data (Supplemental data for manuscript)

Project description:Mass spectrometry is a key analytical platform for metabolomics. The precise quantification and identification of small molecules is a prerequisite for elucidating the metabolism and the detection, validation, and evaluation of isotope clusters in LC-MS data is important for this task. Here, we present an approach for the improved detection of isotope clusters using chemical prior knowledge and the validation of detected isotope clusters depending on the substance mass using database statistics. We find remarkable improvements regarding the number of detected isotope clusters and are able to predict the correct molecular formula in the top three ranks in 92% of the cases. We make our methodology freely available as part of the Bioconductor packages xcms and CAMERA.

2016-10-30 | MTBLS381 | MetaboLights

Optimization and Clinical Validation of a Pathogen Detection Microarray

Project description:Optimization and Clinical Validation of a Pathogen Detection Microarray

| PRJNA99799 | ENA

Clinical Validation of Polydeep: an Artificial Intelligence-based Computer-aided Polyp Detection (CADe) and Characterization (CADx) System

Project description:This study is a clinical validation of Polydeep, a computer-aided polyp detection (CADe) and characterization (CADx) system. Polydeep Advance 1 is an unicentric prospective diagnostic tests trial with a paired study design. The hypothesis of the study is that Polydeep, a CAD system, is more sensitive than a blinded endoscopists for the detection of colorectal polyps in a high definition colonoscopy.

| 2746248 | ecrin-mdr-crc

Validation of an expression signature for lymph node metastasis detection in oral cavity squamous cell carcinoma

Project description:Validation of a previously established gene expression profile for detection of lymph node metastasis (ArrayExpress E-UMCU-11).

2012-10-10 | GSE30788 | GEO

Chromosomal microarray analysis for validation of the NGS-based CNV detection results in clinical samples

Project description:In order to evaluate the performance of CNV detection in next-generation sequencing platform in varied sample types, we employed chromosomal microarray analysis (CMA) for validation of the samples with NGS-based detection results (NCBI Sequence Read Archive with accession number SRA296708). Besides array Comparative Genomics Hybridization (aCGH, Agilent) , we used a commerical SNP-array (Illumina) including early abortus, induced termination, prenatal samples and postnatal samples. CMA results were compared with NGS-based detection results. 100% consistency was obtained between NGS-based approach and CMA in pathogenic or likely pathogenic CNVs detection.

2015-10-01 | GSE73190 | GEO

Validation data for Lawrence Livermore Microbial Detection Array version 2

Project description:Validation data for Lawrence Livermore Microbial Detection Array version 2

| PRJNA133581 | ENA